Published in Int J Hyperthermia on March 27, 1996
Monitoring health inequalities through general practice: the Second Dutch National Survey of General Practice. Eur J Public Health (2005) 5.33
Radiotherapy with or without hyperthermia in the treatment of superficial localized breast cancer: results from five randomized controlled trials. International Collaborative Hyperthermia Group. Int J Radiat Oncol Biol Phys (1996) 3.42
Isolated limb perfusion with high-dose tumor necrosis factor-alpha in combination with interferon-gamma and melphalan for nonresectable extremity soft tissue sarcomas: a multicenter trial. J Clin Oncol (1996) 2.61
Outcome of planned home and planned hospital births in low risk pregnancies: prospective study in midwifery practices in The Netherlands. BMJ (1996) 2.53
Destruction of rat mammary tumor and normal tissue microcirculation by hematoporphyrin derivative photoradiation observed in vivo in sandwich observation chambers. Cancer Res (1986) 2.45
Similar liver transplantation survival with selected cardiac death donors and brain death donors. Br J Surg (2010) 2.30
Increased cancer risk after liver transplantation: a population-based study. J Hepatol (2001) 2.25
Antigenic relatedness of a strongly immunogenic 65 kDA mycobacterial protein antigen with a similarly sized ubiquitous bacterial common antigen. Microb Pathog (1988) 2.23
Direct detection of cytomegalovirus in peripheral blood leukocytes--a review of the antigenemia assay and polymerase chain reaction. Transplantation (1992) 2.21
Service profiles of general practitioners in Europe. European GP Task Profile Study. Br J Gen Pract (1997) 2.17
The importance of the social environment for physically active lifestyle--results from an international study. Soc Sci Med (2001) 2.16
Genetic contribution of FUS to frontotemporal lobar degeneration. Neurology (2010) 2.14
Increased incidence of azathioprine-induced pancreatitis in Crohn's disease compared with other diseases. Aliment Pharmacol Ther (2004) 2.08
Cytomegalovirus antigenemia. Rev Infect Dis (1990) 2.07
Dermatofibrosarcoma protuberans: treatment and prognosis. Eur J Surg Oncol (1992) 1.87
Correlates of exercise compliance in physical therapy. Phys Ther (1993) 1.86
Anatomy and physiology of lymphatic drainage of the breast from the perspective of sentinel node biopsy. J Am Coll Surg (2001) 1.79
Reliability of sentinel lymph node biopsy for staging melanoma. Br J Surg (2000) 1.71
Symptom attribution after a plane crash: comparison between self-reported symptoms and GP records. Br J Gen Pract (2002) 1.63
Progranulin genetic variability contributes to amyotrophic lateral sclerosis. Neurology (2008) 1.56
Positive iliac and obturator nodes in melanoma: survival and prognostic factors. Ann Surg Oncol (1999) 1.55
Genetic variability in progranulin contributes to risk for clinically diagnosed Alzheimer disease. Neurology (2008) 1.55
Repeat isolated limb perfusion with melphalan for recurrent melanoma of the limbs. J Am Coll Surg (1996) 1.54
Lymph node metastasis from melanoma with an unknown primary site. Br J Surg (1990) 1.49
Clear cell sarcoma (malignant melanoma) of soft parts: A clinicopathologic study of 30 cases. Cancer (1999) 1.46
Rapid decreases in donor-specific cytotoxic T lymphocyte precursor frequencies and graft outcome after liver and lung transplantation. Transplantation (2001) 1.42
The role of mycophenolate mofetil in the management of autoimmune hepatitis and overlap syndromes. Aliment Pharmacol Ther (2011) 1.42
[Identification of the sentinel node in patients with breast carcinoma]. Ned Tijdschr Geneeskd (1996) 1.42
Two cases of fatal necrosis of the lesser pelvis in patients treated with combined radiotherapy and hyperthermia for cervical carcinoma. Int J Hyperthermia (2005) 1.39
Progranulin locus deletion in frontotemporal dementia. Hum Mutat (2008) 1.31
Evaluation of mammary lymphoscintigraphy by a single intratumoral injection for sentinel node identification. J Nucl Med (2000) 1.25
Transfer from home to hospital: what is its effect on the experience of childbirth? Birth (1998) 1.25
Prognostic factors for tumor response and limb recurrence-free interval in patients with advanced melanoma of the limbs treated with regional isolated perfusion with melphalan. Surgery (1994) 1.23
Relationship between thermal dose and outcome in thermoradiotherapy treatments for superficial recurrences of breast cancer: data from a phase III trial. Int J Radiat Oncol Biol Phys (1997) 1.22
Frozen section investigation of the sentinel node in malignant melanoma and breast cancer. Ann Surg Oncol (2001) 1.19
Quantitative measurement of cytomegalovirus-specific IgG and IgM antibodies in relation to cytomegalovirus antigenaemia and disease activity in kidney recipients with an active cytomegalovirus infection. Clin Exp Immunol (1990) 1.16
The definition of a sentinel node. Ann Surg Oncol (2001) 1.15
Human tumour pH and its variation. Eur J Cancer Clin Oncol (1985) 1.15
An approach to measuring quality of midwifery care. J Clin Epidemiol (1996) 1.13
Localizing the sentinel node in cutaneous melanoma: gamma probe detection versus blue dye. Ann Surg Oncol (1997) 1.13
Maternity care in The Netherlands: the changing home birth rate. Birth (1998) 1.13
The cytomegalovirus antigenemia assay: a plea for standardization. Scand J Infect Dis Suppl (1995) 1.12
Regional perfusion treatment with melphalan for melanoma in a limb: an evaluation of drug kinetics. Eur J Surg Oncol (1988) 1.10
Surgery for melanoma metastatic to the gastrointestinal tract. Br J Surg (1990) 1.06
History of sentinel node and validation of the technique. Breast Cancer Res (2001) 1.05
Single intralesional tracer dose for radio-guided excision of clinically occult breast cancer and sentinel node. Ann Surg Oncol (2001) 1.04
Effect of hyperthermia on the central nervous system: a review. Int J Hyperthermia (1994) 1.02
The central role of monocytes in the pathogenesis of sepsis: consequences for immunomonitoring and treatment. Neth J Med (1999) 1.02
Low HLA-DR expression on monocytes as a prognostic marker for bacterial sepsis after liver transplantation. Transplantation (1997) 1.00
VWF release and platelet aggregation in human melanoma after perfusion with TNF alpha. J Pathol (1995) 0.98
Vascular complications of isolated limb perfusion. Eur J Surg Oncol (1998) 0.97
Altered lymphatic drainage after lymphadenectomy or radiotherapy of the axilla in patients with breast cancer. Br J Surg (1996) 0.97
Regional variation in hospital admission rates in The Netherlands, Belgium, northern France, Nordrhein-Westfalen. Gesundheitswesen (1992) 0.97
Lymphatic mapping and sentinel lymph node biopsy in breast cancer. Eur J Nucl Med (1999) 0.97
Reliability of lymphoscintigraphy in indicating the number of sentinel nodes in melanoma patients. Ann Surg Oncol (2000) 0.96
Long-term morbidity after regional isolated perfusion with melphalan for melanoma of the limbs. The influence of acute regional toxic reactions. Arch Surg (1995) 0.96
Sentinel node biopsy for melanoma in the head and neck region. Head Neck (2000) 0.96
Plasminogen activator inhibitor 1: biosynthesis and mRNA level are increased by insulin in cultured human hepatocytes. Thromb Haemost (1989) 0.94
Winner of the "New Investigator Award" at the European Society of Hyperthermia Oncology Meeting 2007. The HYPERcollar: a novel applicator for hyperthermia in the head and neck. Int J Hyperthermia (2007) 0.93
Severe acute regional toxicity after normothermic or 'mild' hyperthermic isolated limb perfusion with melphalan for melanoma. Melanoma Res (1995) 0.93
Destructive effect of photoradiation on the microcirculation of a rat mammary tumor growing in "sandwich" observation chambers. Prog Clin Biol Res (1984) 0.93
Sentinel nodes outside lymph node basins in patients with melanoma. Br J Surg (2001) 0.93
Clinical significance of anti-neutrophil cytoplasmic antibodies (ANCA) in autoimmune liver diseases. J Hepatol (2000) 0.92
Low HLA-DR expression on peripheral blood monocytes predicts bacterial sepsis after liver transplantation: relation with prednisolone intake. Transpl Infect Dis (1999) 0.91
Melphalan tissue concentrations in patients treated with regional isolated perfusion for melanoma of the lower limb. Br J Cancer (1994) 0.91
Epithelioid sarcoma. Eur J Surg Oncol (1989) 0.90
Relation between limb toxicity and treatment outcomes after isolated limb perfusion for recurrent melanoma. J Am Coll Surg (1999) 0.90
Thirty-five years of isolated limb perfusion for melanoma: indications and results. Br J Surg (1996) 0.90
Results of regional isolation perfusion with cytostatics in patients with soft tissue tumors of the extremities. Cancer (1989) 0.90
Identification and biopsy of the sentinel lymph node in breast cancer. Eur J Surg Oncol (1998) 0.90
Absence of severe systemic toxicity after leakage-controlled isolated limb perfusion with tumor necrosis factor-alpha and melphalan. Ann Surg Oncol (1999) 0.89
Site-specific and bulk-phase generation of hydroxyl radicals in the presence of cupric ions and thiol compounds. Biochem J (1985) 0.89
Lymphatic mapping with intralesional tracer administration in breast carcinoma patients. Cancer (2000) 0.89
Food allergens in house dust. Int Arch Allergy Immunol (1995) 0.88
Complications of combined radiotherapy and isolated limb perfusion with tumor necrosis factor alpha +/- interferon gamma and melphalan in patients with irresectable soft tissue tumors. J Surg Oncol (1997) 0.88
Expression of p53, p21/WAF/CIP, Bcl-2, Bax, Bcl-x, and Bak in radiation-induced apoptosis in testicular germ cell tumor lines. Int J Radiat Oncol Biol Phys (1998) 0.88
Tumour pH in human mammary carcinoma. Eur J Cancer Clin Oncol (1982) 0.88
Toxicity and morbidity of isolated limb perfusion. Semin Surg Oncol (1998) 0.88
Health policy as a fuzzy concept: methodological problems encountered when evaluating health policy reforms in an international perspective. Health Policy (1997) 0.88
Factors influencing the outcome of radiotherapy in malignant mesothelioma of the pleura--a single-institution experience with 189 patients. Int J Radiat Oncol Biol Phys (1999) 0.88
A 433 MHz Lucite cone waveguide applicator for superficial hyperthermia. Int J Hyperthermia (1998) 0.88
Variation in home-birth rates between midwifery practices in The Netherlands. Midwifery (2000) 0.87
Improved sentinel node visualization in breast cancer by optimizing the colloid particle concentration and tracer dosage. Nucl Med Commun (2001) 0.87
The clinical feasibility of deep hyperthermia treatment in the head and neck: new challenges for positioning and temperature measurement. Phys Med Biol (2010) 0.86
Monitoring for cytomegalovirus after organ transplantation: a clinical perspective. Transplant Proc (1993) 0.86
Long-term functional morbidity after mild hyperthermic isolated limb perfusion with melphalan. Eur J Surg Oncol (1999) 0.86
Isolated perfusion of the limb with high-dose tumour necrosis factor-alpha (TNF-alpha), interferon-gamma (IFN-gamma) and melphalan for melanoma stage III. Results of a multi-centre pilot study. Melanoma Res (1994) 0.86
Lymph node metastases in the neck and parotid gland from an unknown primary melanoma. Clin Otolaryngol Allied Sci (1994) 0.86
Natural killer cell responses in renal transplant patients with cytomegalovirus infection. J Med Virol (1994) 0.85
Patient- and treatment-related factors associated with acute regional toxicity after isolated perfusion for melanoma of the extremities. Am J Surg (1994) 0.85
Normothermic isolation perfusion with melphalan for advanced melanoma of the limbs. Anticancer Res (1987) 0.85
Isolated limb perfusion with high-dose tumor necrosis factor-alpha for locally advanced extremity soft tissue sarcomas. Cancer Treat Res (1997) 0.85
"Owl's eye" cells in a cervical smear of a transplant recipient: don't forget to inform the referring physician. Diagn Cytopathol (2007) 0.85
Hyperthermic isolated limb perfusion with tumor necrosis factor alpha, interferon gamma, and melphalan for locally advanced nonmelanoma skin tumors of the extremities: a multicenter study. Arch Surg (1999) 0.85
Low dose reirradiation in combination with hyperthermia: a palliative treatment for patients with breast cancer recurring in previously irradiated areas. Int J Radiat Oncol Biol Phys (1988) 0.85